Equities
Health CareMedical Equipment and Services
  • Price (SEK)138.70
  • Today's Change1.60 / 1.17%
  • Shares traded62.41k
  • 1 Year change+70.71%
  • Beta1.5145
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year AddLife AB had net income fall -60.42% from 480.00m to 190.00m despite a 6.62% increase in revenues from 9.08bn to 9.69bn.
Gross margin37.30%
Net profit margin1.19%
Operating margin5.50%
Return on assets0.91%
Return on equity2.27%
Return on investment1.29%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at AddLife AB fell by 104.00m. However, the company earned 773.00m from its operations for a Cash Flow Margin of 7.98%. In addition the company used 317.00m on investing activities and also paid 554.00m in financing cash flows.
Cash flow per share8.61
Price/Cash flow per share15.58
Book value per share42.09
Tangible book value per share-22.98
More ▼

Balance sheet in SEKView more

AddLife AB has a Debt to Total Capital ratio of 51.46%, a lower figure than the previous year's 55.24%.
Current ratio1.18
Quick ratio0.638
Total debt/total equity1.06
Total debt/total capital0.5146
More ▼

Growth rates in SEK

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -58.33% and -60.29%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.70%
Div growth rate (5 year)-1.89%
Payout ratio (TTM)52.14%
EPS growth(5 years)4.09
EPS (TTM) vs
TTM 1 year ago
-59.95
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.